{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:48:31Z","timestamp":1769600911536,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jbspin.2015.10.010","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T22:52:18Z","timestamp":1457995938000},"page":"573-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of zoledronic acid in Erdheim-Chester disease: A case report"],"prefix":"10.1016","volume":"83","author":[{"given":"Lucile","family":"Poiroux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Paycha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Polivka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang-Korng","family":"Ea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.10.010_bib0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejim.2015.03.004","article-title":"Erdheim-Chester disease","volume":"26","author":"Campochiaro","year":"2015","journal-title":"Eur J Internal Med"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.02.004","article-title":"Erdheim-Chester disease: systematic review","volume":"95","author":"Cives","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0090","first-page":"876752","article-title":"Rare form of Erdheim-Chester disease presenting with isolated central skeletal lesions treated with a combinaison of alpha-Interferon and Zoledronic Acid","volume":"2015","author":"Bulycheva","year":"2015","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0095","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1148\/radiol.2382041525","article-title":"Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement","volume":"238","author":"Dion","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0100","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2010-10-313510","article-title":"Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single center series of 37 patients","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00296-006-0190-8","article-title":"Treatment of skeletal Erdheim-Chester disease with zoledronic acid: case report and proposed mechanisms of action","volume":"27","author":"Srikulmontree","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0110","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/annrheumdis-2013-204924","article-title":"BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease","volume":"74","author":"Cangi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0115","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targetting the mitogen-activated protein kinase cascade to treat cancer","volume":"4","author":"Sebolt-Leopold","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproductible and sustained efficacy of targeted therapy with Vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease","volume":"33","author":"Haroche","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0130","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2015-01-620377","article-title":"Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial","author":"Gianfreda","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0135","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kev237","article-title":"Treatment failure by canakinumab in a patient with progressive multisystemic Erdheim-Chester disease refractory to anakinra: successful use of vemurafenib","author":"Schirmer","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0140","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.apmr.2004.05.005","article-title":"Erdheim Chester disease: the effect of Bisphosphonate treatment-a case report","volume":"86","author":"Eyig\u00f6r","year":"2005","journal-title":"Arch Phy Med Rehabil"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jbspin.2006.06.005","article-title":"Extra skeletal effects of bisphosphonates","volume":"74","author":"Corrado","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.10.010_bib0150","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1535-7163.MCT-12-0304","article-title":"Zoledronic acid reverses the epithelial-mesenchymal transition and inhibits self-renewal of breast cancer cells through inactivation of NF-kB","volume":"12","author":"Schech","year":"2013","journal-title":"Mol Cancer Ther"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X16000336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X16000336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T09:53:25Z","timestamp":1536918805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X16000336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1297319X16000336"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.10.010","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of zoledronic acid in Erdheim-Chester disease: A case report","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}